IDEXX Laboratories, Inc. IDXX NASDAQ

IDEXX Laboratories, Inc. (IDXX) has shown moderate revenue growth over the past 3 years, expanding from $3.4B to $4.3B (average +8.5%/yr). Net income reached $1.1B, reflecting solid earnings growth at +16.3%/yr on average. The net profit margin is 24.6%, which is high. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 61.8% (high), with a +2.3pp trend over the period. With a $47B market cap and MOAT composite score of 80/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (73/100, Pass) — proving strong growth momentum
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 35-year history, the company was profitable in 33 of 35 years — an excellent long-term track record
• INCOME (85/100, Pass) — proves strong profitability and pricing power
• MOAT (80/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 71/100 with 5/7 criteria passed.